Nathalie Johnson

2PUBLICATIONS
2CO-AUTHORS
BiographyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 07, 2023
Presidential Address: A Long Time Ago in the Future.

Nathalie Johnson

|Aug 20, 2021
Loss of HER2-positivity following neoadjuvant targeted therapy for breast cancer is not associated with inferior oncologic outcomes.

Catherine L Wetzel, Thomas L Sutton, Stuart Gardiner

Pageof 1